Divalproex sodium how supplied storage and handling

Divalproex sodium
DEPAKOTE® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Divalproex sodium
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

How Supplied/Storage And Handling

Depakote tablets (divalproex sodium delayed-release tablets) are supplied as:

125 mg salmon pink-colored tablets:

Bottles of 100………………………………………..(NDC 0074-6212-13)

Unit Dose Packages of 100.................………………(NDC 0074-6212-11)

250 mg peach-colored tablets:

Bottles of 100……………………………………….(NDC 0074-6214-13)

Bottles of 500……………………………………….(NDC 0074-6214-53)

Unit Dose Packages of 100................………………(NDC 0074-6214-11)

500 mg lavender-colored tablets:

Bottles of 100……………………………………….(NDC 0074-6215-13)

Bottles of 500……………………………………….(NDC 0074-6215-53)

Unit Dose Packages of 100................……………...(NDC 0074-6215-11)

Recommended storage

Store tablets below 86°F (30°C).

References

Adapted from the FDA Package Insert.